Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas)

Cytokine

Volumn 56, Issue 2, 2011, Pages 192-199

  Sunderland, Neroli S ^a,b   Thomson, Sally E ^c   Heffernan, Scott J ^c   Lim, Shirlene ^a   Thompson, John ^c   Ogle, Robert ^c   McKenzie, Paul ^c   Kirwan, Paul J ^d   Makris, Angela ^a,e   Hennessy, Annemarie ^a,f  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d Department of Microbiology and Infectious Diseases   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Animal models; Non human primates; Preeclampsia; Pregnancy; Tumor necrosis factor

Indexed keywords

CYTOKINE; ENDOGLIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; NONHUMAN; PAPIO HAMADRYAS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ANIMALS; BASE SEQUENCE; BLOOD PRESSURE; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; PAPIO; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELEMETRY; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; PAPIO; PAPIO HAMADRYAS; PRIMATES;

EID: 80053309308     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.06.003     Document Type: Article

References (35)

1. Lowe S.A., Brown M.A., Dekker G.A., Gatt S., McLintock C.K., McMahon L.P., et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009, 49:242-246.
2. Society of Obstetric Medicine of Australia and New Zealand: Guidelines for the management of hypertensive disorders of pregnancy 2008. In, 2008.
3. Sullivan E, Hall B, King J. Maternal deaths in Australia, 2003-2005. In: AIHW editor, 3rd ed. Sydney: AIHW National Perinatal Statistics Unit; 2008.
4. SOWC: General maternal mortality data. In, UNICEF, 2009.
5. Roberts J.M., Lain K.Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359-372.
6. Makris A., Thornton C., Thompson J., Thomson S., Martin R., Ogle R., et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney International 2007.
7. Maynard S.E., Min J.-Y., Merchan J., Lim K.-H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. The Journal of Clinical Investigation 2003, 111:649-658.
8. Venkatesha S., Toporsian M., Lam C., Hanai J.-i., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nature Medicine 2006, 12:642-649.
9. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England Journal of Medicine 2006, 355:992-1005.
10. Levine R.J., Maynard S.E., Qian C., Lim K.-H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. New England Journal of Medicine 2004, 350:672-683.
11. Gilbert J.S., Babcock S.A., Granger J.P., Gilbert J.S., Babcock S.A. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007, 50:1142-1147.
12. Kurtz T.W., Griffin K.A., Bidani A.K., Davisson R.L., Hall J.E. Subcommittee of P, Public Education of the American Heart A, Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE: Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 2005, 45:299-310.
13. Alexander B.T., Cockrell K.L., Massey M.B., Bennett W.A., Granger J.P. Tumor necrosis factor-[alpha]-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. American Journal of Hypertension 2002, 15:170-175.
14. Makris A., Xu B., Yu B., Thornton C., Hennessy A. Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism. Placenta 2006, 27:445-451.
15. Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004, 145:4838-4845.
16. Devonald K.J., Harewood W.J., Ellwood D.A., Phippard A.F. Fetal ultrasonography: normal biometric ranges in the baboon (Papio hamadryas). Journal of Medical Primatology 1996, 25:339-345.
17. Sunderland N., Heffernan S., Thomson S., Hennessy A., Sunderland N., Heffernan S., et al. Maternal parity affects neonatal survival rate in a colony of captive bred baboons (Papio hamadryas). Journal of Medical Primatology 2008, 37:223-228.
18. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. Journal of Biological Chemistry 2003, 278:12605-12608.
19. Henao D.E., Arias L.F., Mathieson P.W., Ni L., Welsh G.I., Bueno J.C., et al. Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron Exp Nephrol 2008, 110:e73-81.
20. Faas M.M., Schuiling G.A., Baller J.F., Visscher C.A., Bakker W.W. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. American Journal of Obstetrics and Gynecology 1994, 171:158-164.
21. LaMarca B.B.D., Cockrell K., Sullivan E., Bennett W., Granger J.P. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005, 46:82-86.
22. LaMarca B., Wallukat G., Llinas M., Herse F., Dechend R., Granger J.P., et al. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 2008, 52:1168-1172.
23. LaMarca B.B.D., Bennett W.A., Alexander B.T., Cockrell K., Granger J.P. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 2005, 46:1022-1025.
24. Gilbert J.S., Gilbert S.A., Arany M., Granger J.P. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 2009, 53:399-403.
25. Woolcock J., Hennessy A., Xu B., Thornton C., Tooher J., Makris A., et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol 2008, 48:64-70.
26. Ahmad S., Ahmad A. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis. Endothelium 2005, 12:89-95.
27. Li H., Gu B., Zhang Y., Lewis D.F., Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005, 26:210-217.
28. Parra M., Rodrigo R., Barja P., Bosco C., Fernandez V., Munoz H., et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. American Journal of Obstetrics and Gynecology 2005, 193:1486-1491.
29. Pijnenborg R., Vercruysse L., Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006, 27:939-958.
30. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunology Today 1993, 14:353-356.
31. Jokhi P.P., King A., Loke Y.W. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine 1997, 9:126-137.
32. Vince G., Shorter S., Starkey P., Humphreys J., Clover L., Wilkins T., et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clinical and Experimental Immunology 1992, 88:174-180.
33. Matthiesen L., Berg G., Ernerudh J., Ekerfelt C., Jonsson Y., Sharma S. Immunology of preeclampsia. Chem Immunol Allergy 2005, 89:49-61.
34. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. American Journal of Reproductive Immunology 1998, 40:102-111.
35. Houston M.L. The development of the baboon (Papio sp.) placenta during the fetal period of gestation. American Journal of Anatomy 1969, 126:17-29.